Marsh announced the launch of Marsh Nexus Captive Solution on 15 June 2026. The offering operates through its Mangrove Protected Cell Company in Washington, D.C., and is designed for organisations spending more than USD3 million annually on employee benefits outside the United States. The announcement identifies Redion Employee Benefits, formerly Generali Employee Benefits Network, and Zurich as supporting global insurance and reinsurance partners.

Marsh presents Nexus as a way to widen access to captive financing while reducing administrative complexity. These are provider statements about the offering, rather than independently demonstrated savings. The American cell facility is distinct from the proposed British captive regime and from Generali’s separate Redion brand announcement in May 2026.

Establish the programme boundaries For an employer, an initial assessment should identify the countries, benefits and insurance arrangements that could enter the facility. A global spending threshold does not establish that every local policy is suitable. This editor recommends requesting a country schedule showing the intended coverage, local insurer, proposed reinsurance relationship and implementation responsibilities.

That schedule can support discussions between HR, procurement, finance and risk management. Each function needs to understand what changes in its own work. HR should examine employee communications and service access. Finance should understand retained exposure and funding commitments. Procurement should review the operating agreements and the means of holding providers accountable.

Examine responsibilities alongside the structure A cell can reduce the effort involved in establishing a separate insurance company, but an employer still needs a clear account of its obligations. The assessment should cover governance, reporting, capital requirements and the handling of adverse experience. These are questions for programme due diligence, not conclusions that can be drawn from the launch announcement.

Employers should also ask how an exit would work. A decision to discontinue participation may leave claims, reporting or financial obligations that continue beyond the policy year. Written explanations should distinguish the administration of current benefits from the settlement of retained risks. Comparing those commitments with existing arrangements makes the decision more concrete.

The useful next step is an employer-specific feasibility review. It should test the proposed structure against the organisation’s actual insurance portfolio, available data and capacity to oversee the programme. The launch broadens the options available for that review; the business case still depends on the employer’s circumstances.

Sources: Source de référence